Biomarkers in Alzheimer's Disease

12Citations
Citations of this article
187Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Biomarkers in Alzheimer's Disease provides a comprehensive overview of all modalities of Alzheimer's disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer's disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's disease, and for differential diagnosis of Alzheimer's disease with other non-Alzheimer's dementia. Presents a comprehensive overview detailing all modalities of Alzheimer's disease biomarkers Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer's Disease Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer's disease and the technological advancement of biomarkers techniques.

Cite

CITATION STYLE

APA

Khan, T. K. (2016). Biomarkers in Alzheimer’s Disease. Biomarkers in Alzheimer’s Disease (pp. 1–263). Elsevier Inc. https://doi.org/10.18679/cn11-6030_r.2016.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free